Indefinite Delivery Contract SPE2DB24D9238
Award Date
2/27/24
Last Date to Order
12/31/25
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Defense Logistics Agency (DLA) awarded a single-award indefinite delivery contract (IDC) valued at up to $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a broad range of pharmaceutical products and medical supplies to military health facilities globally. The contract, known as SPE2DB, has a period of performance through December 31, 2025. Under this IDC, DMS Pharmaceutical Group will deliver a variety of branded and generic medications, including...
The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) valued at up to $499,999,999 to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The contract, which runs through December 31, 2025, enables DLA to issue firm fixed-price delivery orders for a broad range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. Key product categories include branded and generic medications...
The Defense Logistics Agency (DLA) awarded DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business, a single-award indefinite delivery contract valued at up to $499,999,999 through December 31, 2025. This contract, under the SPE2DB program, enables DLA to issue firm fixed-price delivery orders for a broad range of pharmaceutical items including flumazenil injection, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, and other branded and...
This single-award indefinite delivery contract with a potential value of up to $499,999,999 was awarded to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business, by the Defense Logistics Agency. The contract, under the SPE2DB program, enables the DLA to issue firm fixed-price delivery orders through December 31, 2025 for a broad range of pharmaceutical products to support the recurring medical supply needs of military health facilities globally. Major categories of goods to...
The Defense Logistics Agency (DLA) has awarded a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The contract, which is valid through November 2026, covers an extensive portfolio of branded...
The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) worth up to $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The IDC, valid through November 2026, enables DLA to issue firm fixed-price delivery orders for a diverse portfolio of...
The Defense Logistics Agency (DLA) has awarded a single-award Indefinite Delivery Contract (IDC) valued at up to $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The IDC, which runs through December 31, 2025, covers a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply...
The Defense Logistics Agency (DLA), a logistics combat support agency within the Department of Defense, awarded a single-award indefinite delivery contract (IDC) valued up to $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. This IDC, which runs through December 31, 2025, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to fulfill the recurring medical supply needs of military health...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a comprehensive range of pharmaceutical products and medical supplies to military healthcare facilities worldwide. The IDC, awarded under the SPE2DB program, covers an extensive portfolio of branded and generic prescription drugs, over-the-counter medications,...
The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The contract, which runs through November 2026, covers a diverse portfolio of branded and...